Navigation Links
StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform

MENLO PARK, Calif., May 14 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing clinical systems for Enabling Regenerative Medicine(TM), announced today that it has been awarded a National Institutes of Health Phase I Small Business Innovation Research (SBIR) Grant entitled "Adult Stem Cell Minimally Invasive Bone Marrow Harvester." The award is to further develop the MarrowMiner(TM) which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for harvesting bone marrow.


"We are pleased to have been awarded this grant," commented Vartan Ghazarossian, PhD, President and CEO of StemCor Systems, Inc. "This SBIR award provides further validation of our scientific and clinical approach, to satisfy the unmet need to easily and effectively obtain marrow-derived cells. The grant will be used to broaden our capabilities regarding the harvest of bone marrow, as well as the processing of stem and progenitor cells it contains, for bone marrow transplantation. Additionally," he explained, "the MarrowMiner System has the potential to improve upon a growing number of therapeutic applications in the field of Regenerative Medicine including cardiovascular, neurologic, diabetic and orthopedic disorders."

About the MarrowMiner

The proprietary MarrowMiner System is designed to rapidly and easily harvest stem cell-rich bone marrow in a minimally-invasive manner, in the outpatient setting, and without general anesthesia. This is in contrast to the current practice of bone marrow aspiration through the insertion of a large gauge needle into multiple sites of the iliac crest of the hip, which usually requires general anesthesia, an operating room, and multiple clinical personnel, and results in marrow highly diluted with peripheral blood. Preclinical studies demonstrate that the MarrowMiner can safely harvest large volumes of marrow with significantly higher stem cell activity than is obtained with marrow harvested by means of standard needle aspirates.

About Bone Marrow

Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient's own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.

About Regenerative Medicine

Regenerative medicine focuses on the ability to repair or regenerate damaged, diseased or aging tissues, and is rapidly emerging as the next frontier in medicine. Regenerative therapies have the potential to provide effective treatment for millions of patients worldwide suffering from a wide array of diseases, including cardiovascular, endocrine (i.e. diabetes), neurologic, and orthopedic diseases. A critical aspect of many regenerative therapies is the ability to utilize the patient's own stem and progenitor cells, requiring the harvest, processing, and delivery of these cells to a target organ.

About StemCor

StemCor Systems is a privately held medical device company located in the San Francisco Bay Area developing enabling technologies for regenerative medicine. The company's initial product is the MarrowMiner, a proprietary, minimally-invasive bone marrow collection system. The technology was invented by Daniel Kraft, MD, and was licensed exclusively from Stanford University. Clinical studies are now underway to evaluate the potential of the MarrowMiner System to obtain sufficient and high quality marrow-derived cells.

Contact: Vartan Ghazarossian, PhD

President and CEO

StemCor Systems, Inc.


SOURCE StemCor Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Solei Systems, Inc., Announces That the Company Is Now Publicly Traded
2. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
3. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
4. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
5. QSV Biologics awarded cGMP manufacturing contract by Pfizer Inc.
6. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
7. Chassapis and team awarded $3 million GK-12 grant from NSF for multiscale research
8. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
9. Genomas Awarded $1.2 Million NIH SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy
10. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
11. Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):